MOORE CAPITAL MANAGEMENT, LP - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 92 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.

Quarter-by-quarter ownership
MOORE CAPITAL MANAGEMENT, LP ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$870,000
+50.5%
250,0000.0%0.03%
+17.4%
Q4 2018$578,000
+12.7%
250,000
+400.0%
0.02%
+91.7%
Q2 2014$513,000
+18.8%
50,000
+38.9%
0.01%
+33.3%
Q1 2014$432,00036,0000.01%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Perceptive Advisors 5,995,760$16,129,0001.12%
Palo Alto Investors LP 1,425,439$3,834,0000.29%
Granahan Investment Management 1,438,736$3,870,0000.14%
WealthTrust Axiom LLC 130,000$349,0000.13%
SHEPHERD KAPLAN KROCHUK, LLC 127,846$344,0000.09%
NIPPON LIFE INSURANCE CO 17,192$2,247,0000.06%
Joel Isaacson & Co., LLC 80,660$217,0000.05%
Cornerstone Capital, Inc. 47,200$127,0000.03%
OXFORD ASSET MANAGEMENT LLP 153,769$414,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 281,650$758,0000.01%
View complete list of ACELRX PHARMACEUTICALS INC shareholders